{"id":950527,"date":"2026-04-10T11:48:40","date_gmt":"2026-04-10T15:48:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/"},"modified":"2026-04-10T11:48:40","modified_gmt":"2026-04-10T15:48:40","slug":"aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/","title":{"rendered":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm"},"content":{"rendered":"<div class=\"mw_release\">\n<p>NEW YORK, April  10, 2026  (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of <strong>Aldeyra Therapeutics, Inc. (NASDAQ: ALDX).<\/strong><\/p>\n<p>Shareholders who purchased shares of ALDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p align=\"center\">CONTACT US HERE:<\/p>\n<p align=\"center\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JXBjL7EhahKja14P_o-0gmPCPat-pd8xmh613U5qxWSicNXIMkc6TTbLvM2uGeT2ftkzia2Ib3J7_Qgex8lpHYKF5jeM0C5u5h_MnNYG5zIhNX6-TjoG5Gxwhe86rwIRpObwiMnha2rDUmPO1v7w8MNth9sWY3ke8XqZsRQM8wyqsPpFplUpdOoTzuoGV8l7vcFzcH0D0T_N7R1z6jwliJntiIhQyDMkfn8HCIqRP0wATquRzqKThEp1WlxN4RZEZyohHvcAtnSBcTja8z5kGzdo6swtoVrUoAP_FIO8TI8zIca7fnvuanXjXxrB0B__SZf1Fja1jsMHfeiN0RqDrA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/aldeyra-therapeutics-inc-loss-submission-form-2\/?id=185347&amp;from=3<\/a>\n      <\/p>\n<p>\n        <strong>CLASS PERIOD: <\/strong>November 3, 2023 to March 16, 2026<\/p>\n<p>\n        <strong>ALLEGATIONS: <\/strong>The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) The results of the reproxalap clinical trials were inconsistent; (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful; and (3) as a result, defendants\u2019 statements about Aldeyra\u2019s business, operations, and prospects were materially false and misleading and\/or lacked a reasonable basis at all relevant times.<\/p>\n<p>\n        <strong>DEADLINE: May 29, 2026<\/strong> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JXBjL7EhahKja14P_o-0gmPCPat-pd8xmh613U5qxWSicNXIMkc6TTbLvM2uGeT2ftkzia2Ib3J7_Qgex8lpHYKF5jeM0C5u5h_MnNYG5zIhNX6-TjoG5Gxwhe86rwIRpObwiMnha2rDUmPO1v7w8OzhP25v4h2uVi8bMQGs0WtPaXP01C-ygscdzd4VusWbIGE_-A_1OVo1W9VhcHSAcFUjyftOw59G2uvYc60_pCJPyUYUPliaZ59_Dm7gpaIOWJ6PpfwVVBN0JuxORy-7qXURYYDKdzhN8IizfZCO1Yscm0tqrnGq3qQMfO7s6P6B6_RWovdpVsTycIvCEJ9OGw==\" rel=\"nofollow\" target=\"_blank\">https:\/\/securitiesclasslaw.com\/securities\/aldeyra-therapeutics-inc-loss-submission-form-2\/?id=185347&amp;from=3<\/a><\/p>\n<p>\n        <strong>NEXT STEPS FOR SHAREHOLDERS: <\/strong>Once you register as a shareholder who purchased shares of ALDX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 29, 2026. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <strong>WHY GROSS LAW FIRM? <\/strong>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>CONTACT:<\/strong><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/>New York, NY, 10018<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2AbruUUuA7XmQeaAcVxbFZKwIA8y9Y4qgCJXfhZGx_3Bp6G18cIUf1wf-paU4AeiFFGpWpW5BFjxa9OMn_3rtIukAWl_wuIN8EdvGM45eT7iQNtV03NmcDcgX9qSQ0WK\" rel=\"nofollow\" target=\"_blank\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NjI3MDQ0ZTAtZTM3Yy00YmM5LTg1ZjQtNDY3MGNlYzQ2NmMzLTEyNzA0NjctMjAyNi0wNC0xMC1lbg==\/tiny\/The-Gross-Law-Firm.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Shareholders who purchased shares of ALDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/aldeyra-therapeutics-inc-loss-submission-form-2\/?id=185347&amp;from=3 CLASS PERIOD: November 3, 2023 to March 16, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) The results of the reproxalap clinical trials were inconsistent; (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful; and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950527","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Shareholders who purchased shares of ALDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/aldeyra-therapeutics-inc-loss-submission-form-2\/?id=185347&amp;from=3 CLASS PERIOD: November 3, 2023 to March 16, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) The results of the reproxalap clinical trials were inconsistent; (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful; and &hellip; Continue reading &quot;ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-10T15:48:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm\",\"datePublished\":\"2026-04-10T15:48:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/\"},\"wordCount\":382,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/\",\"name\":\"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\",\"datePublished\":\"2026-04-10T15:48:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/","og_locale":"en_US","og_type":"article","og_title":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk","og_description":"NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) &#8212; The Gross Law Firm issues the following notice to shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Shareholders who purchased shares of ALDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/aldeyra-therapeutics-inc-loss-submission-form-2\/?id=185347&amp;from=3 CLASS PERIOD: November 3, 2023 to March 16, 2026 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (1) The results of the reproxalap clinical trials were inconsistent; (2) the inconsistency of the results rendered any positive findings from these trials unreliable and not meaningful; and &hellip; Continue reading \"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-10T15:48:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm","datePublished":"2026-04-10T15:48:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/"},"wordCount":382,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/","name":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=","datePublished":"2026-04-10T15:48:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NzY0NiM3NTI5NTgzIzIyNTg5MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aldx-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-aldeyra-therapeutics-inc-securities-lawsuit-the-gross-law-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ALDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Aldeyra Therapeutics, Inc. Securities Lawsuit \u2014 The Gross Law Firm"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950527"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950527\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}